Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

The next donor recruitment drives for the Marshall's Match campaign are being held this weekend - with one taking place at AFC Telford's match on Saturday.

In the study, 69 patients with cutaneous T-cell lymphoma, including the most common subtypes mycosis fungoides and Sézary syndrome, were given DD-cxdl for five consecutive days every 21 days.

Drug coverage for four drugs used to treat some rare diseases was announced in Fredericton on Wednesday under a $32 million deal signed by the federal and provincial governments. Under the ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.

Mycosis Fungoides Market Outlook 2025-2035: The mycosis fungoides market is demonstrating a promising trajectory, with a projected CAGR of 5.1% across the 7 major markets between 2025 and 2035. The ...

TOMAHAWK, Wis. (WJFW) – Lincoln County is one of the biggest hotspots in the country for Blastomycosis which is a deadly ...

A benefit is planned for Saturday at 1 pm at the Corner Pub in Tomahawk. There will be raffles, prizes, silent auctions, and free food. All alcohol sold that day will be donated to Christopher and his ...

and escape signs -to have a certificate of mycosis and disinfestation, a pharmacy with first aid supplies as well as a guide ...

Tulmimetostat is under clinical development by MorphoSys and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase I drugs for Mycosis Fungoides have an 85% phase transition ...